Toews Corporation’s Quest Diagnostics DGX Stock Holding History

Toews Corporation’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,300	Closed	-$768K	–	42
2023 Q3	$768K	Buy	+6,300	New	+$839K	0.47%	65
2023 Q1	–	Sell	-5,000	Closed	-$782K	–	48
2022 Q4	$782K	Sell	5,000 -4,200	-46%	-$604K	0.39%	35
2022 Q3	$1.13M	Buy	9,200 +1,300	+16%	+$171K	0.83%	18
2022 Q2	$1.05M	Buy	+7,900	New	+$1.08M	0.7%	99
2018 Q3	–	Sell	-3,300	Closed	-$363K	–	38
2018 Q2	$363K	Buy	+3,300	New	+$344K	0.09%	60

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Toews Corporation's DGX Position: Q4 2023 in Review

Toews Corporation sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 6,300 shares — an estimated $768K sold.

Toews Corporation first reported a position in DGX in Q2 2018 and held it in 5 quarters. The position peaked at $1.13M in Q3 2022. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

Toews Corporation reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
Toews Corporation sold 6,300 Quest Diagnostics shares in Q4 2023, an estimated $768K.
Toews Corporation first reported a position in Quest Diagnostics in Q2 2018 and held it in 5 quarters.
Toews Corporation's Quest Diagnostics position peaked at $1.13M in Q3 2022.
827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Toews Corporation's 13F filing for Q4 2023, filed 17 Jan 2024.